'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
The meetings were a sign of crisis management.
The company has not yet revealed details about the unexplained illness but has stopped trials while doctors find out if the illness was caused due to the vaccine or was a coincidence.
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
A case was lodged on Saturday against Nestle India in a local court here over safety standards of its Maggi product, while actors Amitabh Bachhan, Madhuri Dixit and Preity Zinta have also been separately dragged to the court for promoting the 'two-minute' noodles brand.
Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.
'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products
With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.
The merger has fortified Sun Pharma's position.
At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.
OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.
Nestl India is preparing a blueprint for a possible relaunch.
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
These vaccines have not yet been approved by the World Health Organization
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
Trump also raised the possibility of using light to combat the deadly viral infection.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
Many countries found Maggi noodles to be safe for consumption.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
To focus on molecules at advanced stage of development; move to impact 200 scientists.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.